SARCLISA: A targeted immunotherapy

Designed to find and bind

SARCLISA is not chemotherapy. It is a kind of treatment called a monoclonal antibody — a type of immunotherapy — that works with your body's immune system.

SARCLISA is able to "find and bind" to myeloma cells and helps to stop the spread of multiple myeloma (MM).

SARCLISA works to stop the spread of MM in 3 ways

Finds and binds

The SARCLISA molecule binds to a myeloma cell which alerts an immune system cell to come and destroy the myeloma cell.

SARCLISA finds and binds to myeloma cells and exposes them for elimination by your immune system.

Boosts your immune system

The SARCLISA molecule boosts a trio of immune system cells

SARCLISA helps boost your immune system, making it harder for myeloma cells to survive.

Directly kills

The SARCLISA binds to a myeloma cell, destroying it.

SARCLISA directly kills myeloma cells.

A thumbnail image of the SARCLISA molecule.
A thumbnail image of an immune system cell.
A thumbnail image of a myeloma cell.

SARCLISA is not chemotherapy. SARCLISA is a targeted immunotherapy.

Watch the story of how SARCLISA works to fight Multiple Myeloma

<video-js data-account="5186843675001" data-player="OR7JLFY9F" data-embed="default" data-video-id="6120937590001" class="vjs-fluid"></video-js>

Find out more about how SARCLISA was studied and see the results of the the SARCLISA Phase 3 study.

Quiz icon

Answer 7 short questions to find out if SARCLISA could be appropriate for you.

Take a Short Quiz

Sign-up icon

Stay up to date with the latest information about SARCLISA.

Sign Up